ElendiLabs Logo
Back to Articles

Need Regulatory Help? Try Our Platform

Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.

Registration

September 16, 2025

Approximately 5 minutes

Bangladesh Medical Device Registration: Two-Step DGDA Approval and Validity

Bangladesh Medical Device Registration: Two-Step DGDA Approval and Validity

Medical device registration in Bangladesh is overseen by the Directorate General of Drug Administration (DGDA), operating under the Ministry of Health. This process was formally established and strengthened by the Drugs and Cosmetics Act, 2023 (effective September 18, 2023), which includes software and IVD reagents in its definition of a medical device.


Classification and Required Documentation

Medical devices are classified into four risk categories (A, B, C, D), closely aligning with ASEAN MDD guidelines. The required documentation varies significantly by class:

Device ClassRisk LevelRequired DocumentationValidity
Class ALowCertificate of Free Sale (CFS) from country of originNo Expiry
Class BMedium-LowCFS from country of origin5 Years
Class C/DMedium-High/HighCFS + EC Certificate from a Reference Country (EU, USA, Canada, Japan, Australia)5 Years

Note: ISO 13485 certification is required for all Class B, C, and D devices.

The Mandatory Two-Step Registration Process

Applications for new Market Authorization Certificates for Class B, C, and D devices follow a two-step approval process with the DGDA, typically requiring 4–6 months for completion.

Step 1: Primary Review (Recipe Approval)

  • Purpose: To confirm the completeness of the application with all required technical and administrative documents (submitted as PDF/Xerox copies).
  • Duration: 3–4 months.
  • Outcome: Issuance of a 'Recipe Approval' letter by the DGDA.

Step 2: Final Registration

  • Purpose: Full review of the application and submission of original documents.
  • Key Submission: Original Certificate of Free Sale (FSC) attested by the Bangladesh Embassy, and the original empty product box/label.
  • Duration: 30–40 days after Step 1 completion.
  • Outcome: DGDA issues the final “Registration Certificate – Medical Device/IVD Import.”

Local Representation and Labeling

Foreign manufacturers must appoint a Local Authorized Representative or Distributor to act as the License Holder. Crucially:

  • Only one License Holder is permitted per device at a time.
  • All devices require local labeling after customs clearance, which must prominently display the Maximum Retail Price (MRP) in Bangladeshi Taka (BDT), along with the Importer's Name, Expiry Date, and Batch/Lot number.

Ask Anything

We'll follow up with you personally.

100% response rate • Reply within 7 business days

Your email will not be published. We'll only use it to notify you when we respond.

Questions & Answers (5)

B
Guest

Our high-risk Class D cardiac stents require mandatory laboratory testing in Bangladesh as part of the registration process. How do we legally ship these samples before we have a Registration Certificate? Also, if the National Control Laboratory (NCL) does not have the specific equipment to test our specific stent coating, will DGDA accept our in-house test reports or require us to pay for a foreign lab audit?

ElendiLabs

You must apply for a No Objection Certificate (NOC) for Samples from DGDA first. This NOC allows you to clear a small number of units through customs solely for "Testing and Registration Purposes." If the NCL lacks the technical capacity to test your device (which is common for Class D), the DGDA Technical Committee will usually request a "Method Validation Report" and may allow the use of your own ISO 17025 accredited lab reports. However, in 2026, DGDA has been increasingly requesting "Sample Analysis" via a local government-designated expert physician to verify the clinical handling of the device before the final Registration Certificate is issued.

A
Guest

We want to appoint a third-party regulatory consultant in Dhaka as our Local Authorized Representative (AR) to hold the Market Authorization (MA). However, we have three different commercial distributors for northern and southern Bangladesh. Does DGDA's 2026 portal allow one registration certificate to be linked to multiple Import Permissions (IP) for different distributors? What is the risk of the AR "holding our license hostage"?

N
Guest

我们计划在孟加拉推广一套基于云端的 AI 辅助诊疗系统。根据《2023 年药品与化妆品法案》,软件已被正式纳入“药品”范畴监管。对于这类 SaMD,如果其服务器位于孟加拉境外,DGDA 在注册时是否会提出数据本地化或本地服务器审计的要求?

ElendiLabs

In Bangladesh, the AR who holds the Registration Certificate has significant control. Under the current DGDA framework, the AR must issue a Letter of Authorization to individual distributors so they can apply for their own Import Permission (IP) for specific shipments. It is highly recommended to use an independent third-party AR rather than a distributor, because changing the AR in Bangladesh requires a No Objection Certificate (NOC) from the existing representative. Without a clear contract, an uncooperative distributor-AR can effectively block you from re-registering or switching partners.

ElendiLabs

2023 年法案确实将软件(Software)列入监管。目前 DGDA 将大多数诊断类 AI 划分为 Class C。虽然 DGDA 尚未建立完善的数据安全法,但在注册 Dossier 中,您必须详细说明数据传输协议(Protocol)和隐私保护机制。DGDA 的技术委员会(DCC)在 2026 年的评审中,开始关注软件的“本地化适应性”,即您必须证明该 AI 模型在南亚人群数据上经过验证或具有适用性,否则可能被要求在本地进行小规模临床验证。

A
Guest

我们是一款中国制造的 C 类植入物,已获得 CE 认证。DGDA 要求提交由孟加拉驻华使馆认证(Attestation)的 FSC。如果我们无法提供原产国(中国)的使馆认证 FSC,但能提供由荷兰或德国签发的 FSC,是否可以被接受?

ElendiLabs

根据 DGDA 的“参考国”原则,C 类和 D 类高风险产品必须提供来自参考国(美国、欧盟、加拿大、日本、澳大利亚)的 FSC。由于您的产品是中国制造,您必须提供两份 FSC:一份是原产国(中国)的 FSC,且必须经过孟加拉驻华使馆认证;另一份是上述参考国之一的 FSC。2026 年的最新政策对使馆认证要求非常严苛,任何未经认证的副本在第二阶段评审中都会被退回。

A
Guest

我们的二类(Class B)体外诊断试剂已经准备好了全套 CSDT 文件。在孟加拉国,是否可以直接提交最终注册?听说 DGDA 有一个“第一步:配方审批”的要求,这是否意味着我们要像药品一样提交详细的原材料清单和生产配方?

ElendiLabs

这是一个孟加拉国特有的流程。根据 DGDA 2026 年的实务,所有 B、C、D 类医疗器械必须先经过 Recipe Approval(第一阶段)。对于器械,DGDA 要求提交 "Master Formula" 的简化版,重点在于产品组成部件的详细规格和来源。只有在获得配方审批信后,您才有资格进入第二阶段(正式注册)。如果第一阶段的材料不完整,将无法通过 DGDA 的初审。

Need Expert Guidance?

Contact us at contact@elendilabs.com / +852 4416 5550